Working… Menu
Trial record 16 of 50 for:    "Elephantiasis" | "Anti-Infective Agents"

Mass Drug Administration for Lymphatic Filariasis and Onchocerciasis for Liberia (DOLF-LIBERIA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01905436
Recruitment Status : Completed
First Posted : July 23, 2013
Last Update Posted : May 4, 2018
Information provided by (Responsible Party):
Gary Weil, MD, Washington University School of Medicine

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : April 2017
Actual Study Completion Date : July 2017